Chemoinformaics analysis of CYCLOHEXA-1,4-DIENE
| Molecular Weight | 80.13 | nRot | 0 |
| Heavy Atom Molecular Weight | 72.066 | nRig | 22 |
| Exact Molecular Weight | 80.0626 | nRing | 1 |
| Solubility: LogS | -7.371 | nHRing | 0 |
| Solubility: LogP | 7.869 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 15.3543 |
| nHD | 0 | BPOL | 8.02566 |
| QED | 0.276 |
| Synth | 4.828 |
| Natural Product Likeliness | 2.81 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.647 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -4.722 |
| MDCK | 0.00000751 |
| BBB | 0.914 |
| PPB | 0.989016 |
| VDSS | 2.146 |
| FU | 0.0148641 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.415 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.108 |
| CYP2c9-sub | 0.347 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.846 |
| CYP3a4-inh | 0.317 |
| CYP3a4-sub | 0.617 |
| CL | 8.114 |
| T12 | 0.006 |
| hERG | 0.019 |
| Ames | 0.021 |
| ROA | 0.095 |
| SkinSen | 0.014 |
| Carcinogencity | 0.037 |
| EI | 0.008 |
| Respiratory | 0.638 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.937152 |